National and Kapodistrian University of Athens
Μελέτη της ρύθμισης της γονιδιακής έκφρασης των καλλικρεϊνών και της L-DOPA αποκαρβοξυλάσης, μέσω των μορίων microRNA, στον καρκίνο του μαστού: αξιολόγηση της διαφοροδιαγνωστικής, προβλεπτικής και προγνωστικής αξίας
Abstract
dc:descriptionAim of the study: The expression analysis and clinical evaluation of KLK8 and DDC, as well as the microRNA molecules which target the genes of interest, miR-224 and miR-145. Materials and Methods: Breast tissues (cancerous and non-cancerous, N=250) were homogenized and total RNA was extracted, polyadenylated (for miRNA analyses) and reverse transcribed into cDNA. Using different miRNA target prediction algorithms, we selected for further analysis two miRNAs, miR-224 and miR-145. Thereafter, KLK8, DDC and miR-224 and miR-145 expression levels, were quantified using Real-Time PCR. The clinical evaluation of the prognostic and the differential diagnostic potential of the biomolecules under study, was accomplished by using extensive biostatistical analyses. Results – Conclusion: Multivariate analysis showed that KLK8 expression is a strong and independent predictor of adverse DFS in breast cancer (HR=4.54, P=0.004). DDC mRNA levels were increased in a statistically significant degree in Ki67 positive (P=0.023) and high histological grade breast tumors (P=0.020). DDC mRNA expression was identified as strong independent indicator of unfavorable outcome with regard to DFS, for breast cancer patients (HR=3.82, P=0.033). In the case of miR-224, we observed that high-levels of miR-224 expression, is also a significant unfavorable prognostic marker independent of other clinicopathological factors (HR=4.86, P=0.014). miR-145, was found to be lower in high histological grade breast tumors (P<0.001) and in Ki67 positive ones (P<0.001). It is worth mentioning here, that DDC expression profile was the exact opposite in breast tumors with these clinicopathological features. In conclusion, the biomolecules under study, represent promising molecular indicators that could aid in the differential diagnosis and provide accurate prognostic information for breast cancer patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Michaelidou, Kleita
- Μιχαηλίδου, Κλείτα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36555